Research Article
Change in Motor and Nonmotor Symptoms Severity in a “Real-Life” Cohort of Subjects with Parkinson’s Disease
Table 2
Parkinson’s disease change in severity based on MDS-UPDRS severity scale.
| MDS-UPDRS | Initial evaluation | Follow-up | value |
| MDS-UPDRS Part I | | | | Mild | 33 (62.3%) | 35 (66%) | 0.751 | Moderate | 17 (32.1%) | 15 (28.3%) | 0.789 | Severe | 3 (5.7%) | 3 (5.7%) | 0.617 | MDS-UPDRS Part II | | | | Mild | 34 (64.2%) | 37 (69.8%) | 0.579 | Moderate | 17 (32.1%) | 13 (24.5%) | 0.422 | Severe | 2 (3.8%) | 3 (5.7%) | <0.99 | MDS-UPDRS Part III | | | | Mild | 36 (67.9%) | 38 (71.7%) | 0.789 | Moderate | 14 (26.4%) | 14 (26.4%) | 0.802 | Severe | 3 (5.7%) | 1 (1.9%) | 0.617 | MDS-UPDRS Part IV | | | | Mild | 49 (92.5%) | 45 (84.9%) | 0.288 | Moderate | 4 (7.5%) | 8 (15.1%) | 0.288 | Severe | 0% (0) | 0% (0) | — |
|
|
MDS-UPDRS: Movement Disorder Society Unified Parkinson’s Disease Rating Scale.
|